EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSMOCG00000022944
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMOCG00000013079
Gene Symbol: TUBA4A
3 Cross references
224 Possible Orthologues:

Tubulin Alpha-1 Chain

Ensembl ID : ENSMOCG00000007049
Gene Symbol: LOC101985375
2 Cross references
124 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSMOCG00000011887
Gene Symbol: LOC101998227
3 Cross references
119 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSMOCG00000020454
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSMOCG00000021775
Gene Symbol: TUBB2A
3 Cross references
182 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMOCG00000006039
Gene Symbol: TUBB3
3 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMOCG00000015551
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSMOCG00000001389
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMOCG00000009265
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta-2b Chain

Ensembl ID : ENSMOCG00000021829
Gene Symbol: LOC101999161
3 Cross references
181 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSMOCG00000020008
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).